Summary. Sympathetic nerve terminals were destroyed by administration of 6\ x =r eq-\ hydroxydopamine (2 \m=x\50 mg/kg) at 10:00 h on Days 4 and 5 of pregnancy in the rat. In the myometrium, this treatment markedly decreased noradrenaline concentrations (by 99%, P < 0.001), demonstrating that myometrial noradrenaline is mainly originated from sympathetic nerves; therefore after 6-hydroxydopamine, the distribution and spacing of blastocysts remain unaffected throughout the uterus.
Introduction
In polyovulating animals blastocysts become spaced throughout the uterine horns, suggesting that their intrauterine distribution and equidistant spacing are a common inherent characteristic to minimize early embryo mortality. An increase in the number of implantation sites leads to a decrease in the mean distance between the sites. The reason why this type of distribution occurs is unknown. The most likely explanation for intrauterine migration and uniformity of spacing includes an involvement of myometrial activity as suggested by Böving ( 1956) for the rabbit, McLaren & Michie (1959) for the mouse and Rexroad & Guthrie (1983) for the pig. The fact that intravenous infusion of a potent myometrial inhibitor, pig relaxin, to rats disorganized the distribution of fertilized ova in the uterus (Pusey et al, 1980) also supports this view.
The extensive network of adrenergic nerves in the rat uterus (Papka et al, 1985) and the responsiveness of the myometrial cells to catecholamines (Chow & Marshall, 1981) has led us to the suggestion of a role for the autonomie nervous system in the regulation of myometrial motility at the time of intrauterine blastocyst migration. Roche et al (1985) have reported that, when adrenergic innervation of the upper uterine horn was eliminated by freezing of the ovarian nerve supply, the number and spacing of conceptuses at Day 7 of pregnancy was unaffected. Since a substantial adrenergic innervation of the uterus may be from the paracervical ganglion (rat: Kanerva, 1972;  guinea-pig: Bell & Malcolm, 1978) , destruction of the ovarian nerve supply could be interpreted as causing incomplete or no denervation of the uterine horns. It therefore remains unclear whether a sympathetic noradrenergic transmission was required for blastocyst migration and distribution. The present experiments in the rat were designed to evaluate the effects of the neurotoxin 6-hydroxydopamine, and those of phenoxybenzamine or prazosin, on uterine transport and spacing of blastocysts. Phenoxybenzamine is a much more potent inhibitor of at-than of a2-adrenoceptors (Dubocovich & Langer, 1974) , but treatment with phenoxybenzamine also partly affected the func¬ tion of a2-adrenoceptors responsible for the inhibition of preloaded release of noradrenaline in the brain (McKernan & Campbell, 1986) . Prazosin is a powerful post-synaptic a!-adrenergic blocking agent (Ruffolo, 1984) .
The purpose of this paper was therefore to elucidate whether the sympathetic noradrenergic transmission via action on post-synaptic a,-adrenoceptors of the myometrium is a physiological regulatory mechanism for uterine blastocyst distribution in the rat.
Materials and Methods

Animals
Virgin female Sprague-Dawley rats weighing between 250 and 300 g were housed under controlled temperature (22°C) and photoperiod (10 h light and 14 h darkness with the lights on from 08:00 to 18:00 h). Food (1958) . The normetanephrine was then extracted and isolated by thin-layer chromatography. The tritiated normeta¬ nephrine was scraped off, converted to vanillin by periodate cleavage and thereafter extracted into toluene. The radioactivity was measured by liquid scintillation counting in an LKB-Wallac spectrometer (1214 Rackbeta). Assay sensitivity was 4 pg/ml for uterine supernatant. Inter-assay coefficient of variation was 5% and intra-assay variation was 8% which is in the range of the values reported by Da Prada & Zürcher (1976) in plasma.
Treatments Group 1. At 10:00 h on Days 4 and 5 of pregnancy animals were injected intraperitoneally with 0-5 ml 6-hydroxydopamine (6-OHDA) hydrobromide (Sigma, St Louis, MO, U.S.A.), 5 mg/100 g body weight, dissolved in 0-9% (w/v) NaCl solution containing 10 mg ascorbic acid/ml. This treatment induced a consistent long-lasting disappearance of endogenous noradrenaline (Thoenen & Tranzer, 1968) . A control group received 0-5 ml vehicle only.
Group 2. At 10:00 h on Days 4 and 5 of pregnancy animals were injected into the saphenous vein with 2 mg phenoxybenzamine. The phenoxybenzamine was dissolved in 2 mM-tartaric acid and diluted by one half with 150 idmNaCl. A control group of 6 females received vehicle only. A suitable dose and time of exposure to phenoxybenzamine was chosen from pilot experiments (Sladeczek & Bockaert, 1983; Maltier & Legrand, 1985) .
Group 3. At 12:00h and 18:00h on Day 4 and at Oh, 06:00h and 12:00h on Day 5, females were injected sub¬ cutaneously with 0-5 ml saline (9 g NaCl/1) containing 20% ethanol plus 1 mg prazosin-HCl (Pfizer, Brussels, Belgium). This timing for injection of a repetitive bolus dose of prazosin has been established because the half life of the drug has been estimated as2-9 + 0-8 h(Jaillone/a/., 1979;Baughmane/a/., 1980; Timmermans& Van Zwieten, 1984) . Acontrol group of 5 females received vehicle only.
In all groups of rats at 17:00 h on Day 5, animals were lightly anaesthetized with ether and 1 ml of a 1% Evans' blue solution in saline (9 g NaCl/1) was injected into the saphenous vein. After 30 min, a ventral laparotomy was performed and the uterine horns were examined. Blue reaction sites indicated an increased endometrial capillary permeability (Psychoyos, 1961 (Psychoyos, , 1971 at the location of the blastocysts. The localization of blastocysts by identifying surrounding areas of increased vascular permeability using an intravascular injection of Evans' blue dye is a well accepted method (Finn & Porter, 1975) . In these conditions, the number, size and position of the blue reaction sites were estimated in each uterine horn. Their spacing and the length of the horn were recorded on millimetre paper. (Snedecor & Cochran, 1957) .
Results
Noradrenaline concentrations in uterine tissues
Noradrenaline myometrial levels in early pregnant rats are shown in Fig. 1 58-9 ± 7-9 0-23+0-01Î (10)
62-9 ± 15-4 (10) 0-24 ± 0-02Î
511 + 10-8
0-30 ± 0-071 (6) 26-1 ± 6-4*t 0-17 +005t.
(12) in all 3 rats examined. In rats killed at 17:00 h blastocysts were distributed in both portions of the uterus in 70% of the horns examined; the mean numbers of blastocysts recovered from the upper and lower portions were 1-75 ± 1-1 and 1-25 ± 0-75, respectively. At 17:00 h on Day 5,15 uterine horns of untreated rats and 11 uterine horns of animals receiving the vehicle for drugs were examined. The mean number of blue sites was not different between untreated rats (61 ± 0-7) or vehicle-treated rats (5-8 ± 0-5) and between left horns or right horns (5-5 + 0-8 and 6-5 + 0-7, respectively) and so the values were pooled. The total number of implan¬ tation sites expected for rats at this stage of pregnancy was therefore 11-9 + 1-5 and there was no correlation between the different lengths of each individual horn and the number of blue site reactions that it contained (r Treated rats. Treatment with phenoxybenzamine (Group 2) or prazosin (Group 3) induced a significant reduction of the mean number of blue sites in the uterine horns of animals killed in the afternoon of Day 5 of pregnancy (Fig. 3) . In these treated rats, the recovery rate of blastocysts estimated on Day 5 was greatly reduced: to .53% after prazosin, and to 57% after phenoxybenzamine. Moreover, when distribution of blue sites was tested along the different portions of the uterine horns we noted that prazosin and phenoxybenzamine resulted in a greater number of blastocysts located in the upper portion of the uterus (Fig. 4) . In addition, treatment with prazosin seriously disturbed the regular distribution of blue reaction sites since the spacing between the sites and the number of the sites was no longer correlated (r = -0143, = 11; > OT, Fig. 2 ). In contrast, treatment with 6-OHDA did not affect number, spacing or distribution of blue sites (Figs 3 & 4) .
Discussion
The results of this study reveal a sharp increase in myometrial concentrations of noradrenaline in rats between Days 3 and 4 of pregnancy, i.e. just before the blastocysts began to move to the uterus: in our colony, transfer of fertilized ova to the uterine horns begins between 11:00 h and 14:00 h on Day 4 and is achieved by the morning of Day 5. This observation is in good agreement with previous data of Forcelledo et al. (1981) and Villalon et al (1982) for the same strain of rats (Sprague-Dawley). When all blastocysts were present in the uterus noradrenaline concentration remained constant in the inter-blastocyst segments (non-blue areas) whereas it decreased sharply in periblastocyst myometria (blue area, -50%). Later during pregnancy (Day 21), Arkinstall & Jones (1985) also detected small concentrations of noradrenaline in perifetal myometrium while cervical noradrenaline showed the greatest conservation. The physiological significance of such a nor¬ adrenaline withdrawal from the myometrium surrounding blastocysts is unknown but it is likely that the ability of the adrenergic neuromediator to elicit a contractile response is considerably limited at this site. It is suggested that local regulatory signals could account for this difference; they could either originate from the blastocyst at its implantation site, or be associated with decidual tissue development as suggested by Garris & Dar (1985) for the guinea-pig. At the present time the exact mechanisms responsible for these changes in tissue bioamine levels of the rat myometrium adjacent to the site of implantation are highly speculative and remain to be determined. In the guineapig between Day 16 and Day 22 of pregnancy, Bell & Malcolm (1978) described a disappearance of formaldehyde-induced fluorescence from the uterine wall immediately around the site of implantation and they presented evidence that it is due to an effect of placental progesterone.
Chemical sympathectomy by 6-OHDA (Tranzer & Thoenen, 1967; Malmfors & Sachs, 1968) , which depletes up to 99% of myometrial noradrenaline demonstrated that, in this tissue, endo¬ genous noradrenaline could be mainly derived from sympathetic nerve endings. This is in good agreement with our observations in the late pregnant rat uterus (Legrand & Maltier, 1986; Maltier et al, 1987) . But, as shown in this study, the 6-OHDA used to interfere with the nerve supply to the uterus did not alter blastocyst transport or distribution. This observation is in good agreement with the assumption of Roche et al (1985) , who froze the ovarian adrenergic nerves supplying the upper part of the rat genital tract, that sympathetic denervation did not interfere with the establishment of pregnancy. According to the same authors, ovarian secretion of progesterone and oestradiol, hormones that are important in early pregnancy, was not impaired after denervation. However, our results, which demonstrate that number, distribution and spacing of blue site areas can be disrupted by c^-adrenoceptor blocking agents (prazosin or phenoxybenzamine), provide indirect evidence that a noradrenergic transmission is involved in the control of myometrial activity necessary for intrauterine migration and positioning of blastocysts through the uterine horns. The reason why there is some inconsistency between the effects of the two treatments is unknown. A phenom¬ enon of denervation supersensitivity rapidly developing in smooth muscle after chemical sympath¬ ectomy has been reported (Trendelenburg et al, 1962) . Denervation experiments seem to have their limitations in demonstrating the transmitter action on the effector organ. In rat myometrial frac¬ tions, a-adrenoceptors have been well characterized with specific binding of tritiated radioligand antagonists (cyclic rat: Krall et al, 1978; pregnant rat; Maltier & Legrand, 1985) ; this authorizes a pharmacological approach to the function of the ¡-adrenoceptors, possibly mediating contractile response of the uterus during intrauterine blastocyst transfer, by the use of o^-blockers, and our experiments are conclusive. When prazosin or phenoxybenzamine was administered in the morning of Day 4, the reduction of implantation sites (blue areas) could have been due to the fact that the drug altered rates of ovum transport through the oviduct (Polidoro et al, 1973) . However, no fertilized ova were recovered from dissected and washed oviducts at 10:00 h on Day 6. based upon this observation we consider that both drugs either could have a deleterious effect on intrauterine blastocyst survival, or, more probably, inhibit a contractile mechanism implicated in the retention of the blastocysts once located in the lower segment of uterine horns. Arkinstall & Jones (1985) have shown that noradrenaline concentration in pregnant rats is relatively high at the cervical end of the uterus and this reinforces the probability that noradrenaline could be a potent regulator of utero-cervical smooth muscle activity. Our results clearly suggest that, in the rat, an c^-mediatedcontractile response of the myometrium is involved in the distribution and regular spacing of blastocysts moving from the utero-tubal junction to the cervix and probably in their retention at the utero-cervical end of the horns. Other mechanisms which could regulate the activity of the myometrium are also probably involved, since distribution of blastocysts can be disrupted by infusion of relaxin (Pusey et al, 1980 
